Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 196–210 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-6191 CYP11B2 Gene Sequencing for Congenital Hypoaldosteronism (CMO II Deficiency) Test This test identifies pathogenic variants in the CYP11B2 gene associated with congenital hypoaldosteronism (CMO II deficiency).	Whole Blood (EDTA) or Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CYP11B2 gene"] Parameters [] Preparation ["Genetic counseling session required", "Clinical history documentation required", "Pedigree chart documentation required"] Indications ["Suspected congenital hypoaldosteronism", "Family history of CMO II deficiency", "Screening of affected family members"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: E27.4 Clinical summary This test identifies pathogenic variants in the CYP11B2 gene associated with congenital hypoaldosteronism (CMO II deficiency).
TEST-6304 CYP1A2 Gene Cytochrome P450 Deficiency Genetic Test This genetic test evaluates the CYP1A2 gene for variants that affect drug metabolism capacity.	Whole Blood (peripheral) or Dry Blood Spot on FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP1A2 gene variants", "Metabolic capacity for specific drugs"] Parameters [] Preparation ["Pre-test genetic counselling session required", "Pedigree chart documentation required"] Indications ["Personalised medication dosing", "Reducing adverse drug reactions", "Pharmacogenomic risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 69900-6 ICD-10: Z13.71, Z13.79, Z15.89 Clinical summary This genetic test evaluates the CYP1A2 gene for variants that affect drug metabolism capacity.
TEST-6135 CYP7B1 Gene Bile Acid Synthesis Defect Type 3 Congenital Genetic Test This test identifies genetic variants in the CYP7B1 gene associated with congenital bile acid synthesis defect type 3.	Whole Blood (2–3 mL EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP7B1 gene sequence", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions"] Indications ["Suspected congenital bile acid synthesis defect type 3", "Family history of the disorder", "Evaluation of unexplained liver disease or neurological symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 92791-8 ICD-10: E78.70 Clinical summary This test identifies genetic variants in the CYP7B1 gene associated with congenital bile acid synthesis defect type 3.
TEST-5690 CYP7B1 Gene SPG5A Genetic Test This test identifies pathogenic variants in the CYP7B1 gene, which are responsible for hereditary spastic paraplegia type 5A (SPG5A).	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP7B1 gene sequence", "Pathogenic variants (point mutations, insertions/deletions, splice-site variants)"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": ">99.9%"}, {"name": "Analytical Specificity", "reference_range": ">99%"}] Preparation ["No special diet or medication stop is needed"] Indications ["Unexplained progressive lower-limb spasticity", "Gait disturbance", "Positive family history of autosomal recessive spastic paraplegia", "Differentiation from other spastic paraplegias", "Reproductive risk counselling"] Measurement technique Confirm with laboratory Codes LOINC: 81205-3 ICD-10: G11.4 Clinical summary This test identifies pathogenic variants in the CYP7B1 gene, which are responsible for hereditary spastic paraplegia type 5A (SPG5A).
TEST-6208 D2HGDH Gene Next‑Generation Sequencing (NGS) Test for D‑2‑Hydroxyglutaric Aciduria Type 1 This test evaluates the D2HGDH gene for pathogenic variants associated with D‑2‑hydroxyglutaric aciduria type 1.	Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["D2HGDH gene sequence", "Pathogenic variants"] Parameters [] Preparation ["No specific fasting required", "Avoid sample collection during acute hemolytic crisis or within 4 weeks of a blood transfusion"] Indications ["Suspected D‑2‑hydroxyglutaric aciduria type 1", "Family history of the disorder", "Neurological symptoms suggestive of a neurometabolic disorder"] Measurement technique Confirm with laboratory Codes LOINC: 78014-4 ICD-10: E72.8 Clinical summary This test evaluates the D2HGDH gene for pathogenic variants associated with D‑2‑hydroxyglutaric aciduria type 1.
TEST-4209 DBH Gene (Dopamine Beta-Hydroxylase) Deficiency Genetic Test This genetic test evaluates the dopamine beta-hydroxylase (DBH) gene for variants associated with DBH deficiency, a rare disorder affecting autonomic function.	Peripheral Whole Blood (EDTA) or FTA Card	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DBH gene", "Copy-number alterations in the DBH gene", "Deep intronic mutations in the DBH gene"] Parameters [] Preparation ["Do not discontinue prescribed medication without physician instruction"] Indications ["Individuals with unexplained fainting episodes", "Individuals with low blood pressure upon standing", "Individuals with exercise intolerance", "Individuals with a family history of sudden cardiac events despite normal cardiac workup"] Measurement technique Confirm with laboratory Codes LOINC: 94086-1 ICD-10: E70.8 Clinical summary This genetic test evaluates the dopamine beta-hydroxylase (DBH) gene for variants associated with DBH deficiency, a rare disorder affecting autonomic function.
TEST-3732 DCPS Gene Al-Raqad Syndrome Genetic Test This test provides a definitive molecular diagnosis for Al-Raqad syndrome by sequencing the entire DCPS gene.	Peripheral Whole Blood (EDTA) • Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DCPS gene sequence", "Copy Number Variants (CNV) in DCPS gene"] Parameters [] Preparation ["Provide complete clinical history", "Provide family pedigree"] Indications ["Suspected Al-Raqad syndrome", "Family history of Al-Raqad syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 81329-1 ICD-10: Q87.8 Clinical summary This test provides a definitive molecular diagnosis for Al-Raqad syndrome by sequencing the entire DCPS gene.
TEST-5009 DDX3X Gene X‑Linked Intellectual Disability Type 102 Genetic Test This genetic test analyzes the DDX3X gene to detect pathogenic variants associated with X-linked intellectual disability type 102.	Whole blood (EDTA), buccal swab, or extracted DNA	3–4 weeks (STAT 7 days available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DDX3X gene", "Copy number variants (CNVs) in the DDX3X gene"] Parameters [] Preparation [] Indications ["Males with unexplained global developmental delay, moderate-to-severe intellectual disability, hypotonia, and/or movement disorders", "Females with mild intellectual disability or skewed X-inactivation"] Measurement technique Confirm with laboratory Codes LOINC: 94222-4 ICD-10: F78.9 Clinical summary This genetic test analyzes the DDX3X gene to detect pathogenic variants associated with X-linked intellectual disability type 102.
TEST-6007 DECR1 Gene Analysis (2,4-Dienoyl-CoA Reductase 1) Genetic Test This test detects pathogenic variants in the DECR1 gene associated with mitochondrial fatty acid oxidation disorders.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DECR1 gene", "Single-nucleotide variants", "Small indels"] Parameters [] Preparation ["Pre-test genetic counselling session is mandatory"] Indications ["Unexplained hypoglycaemia", "Skeletal myopathy", "Dilated cardiomyopathy", "Family history of fatty acid oxidation disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E71.318, Z15.89, E88.89 Clinical summary This test detects pathogenic variants in the DECR1 gene associated with mitochondrial fatty acid oxidation disorders.
TEST-4342 DEPDC5 Genetic Test for Familial Focal Epilepsy with Variable Foci This test identifies pathogenic variants in the DEPDC5 gene associated with familial focal epilepsy with variable foci.	Peripheral Blood, Extracted DNA, or Dried Blood Spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DEPDC5 gene sequence", "Copy Number Variations (CNV) in DEPDC5 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Diagnosis of familial focal epilepsy with variable foci", "Family risk assessment", "Guiding antiepileptic therapy"] Measurement technique Confirm with laboratory Codes LOINC: 96609-6 ICD-10: G40.0 Clinical summary This test identifies pathogenic variants in the DEPDC5 gene associated with familial focal epilepsy with variable foci.
TEST-3721 DHH Gene Mutation Analysis for 46,XY Gonadal Dysgenesis & Minifascicular Neuropathy Test This diagnostic test evaluates the DHH gene for pathogenic variants associated with 46,XY gonadal dysgenesis and minifascicular neuropathy.	Peripheral Whole Blood, Serum, or Plasma	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DHH gene", "Coding exons and intron-exon boundaries"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any anticoagulant therapy"] Indications ["Suspected 46,XY gonadal dysgenesis", "Suspected minifascicular neuropathy", "Family history of DHH-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 50396-0 ICD-10: Q99.1, G60.0 Clinical summary This diagnostic test evaluates the DHH gene for pathogenic variants associated with 46,XY gonadal dysgenesis and minifascicular neuropathy.
TEST-6010 DHTKD1 Gene Analysis (2-Aminoadipic 2-Oxoadipic Aciduria) Test This test identifies pathogenic variants in the DHTKD1 gene associated with 2-aminoadipic 2-oxoadipic aciduria.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DHTKD1 gene"] Parameters [] Preparation ["Do not discontinue prescribed medication without physician instruction", "Pre-test genetic counseling session required"] Indications ["Suspected 2-aminoadipic 2-oxoadipic aciduria", "Family history of the disorder", "Confirmation following suggestive biochemical screening"] Measurement technique Confirm with laboratory Codes LOINC: 81261-8 ICD-10: E72.52 Clinical summary This test identifies pathogenic variants in the DHTKD1 gene associated with 2-aminoadipic 2-oxoadipic aciduria.
TEST-5907 DLAT Gene (Pyruvate Dehydrogenase E2 Deficiency) Genetic Test This genetic test identifies pathogenic variants in the DLAT gene associated with Pyruvate Dehydrogenase E2 Deficiency.	Peripheral Whole Blood / FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DLAT gene sequence variants", "Pathogenic mutations in coding exons and flanking intronic regions"] Parameters [] Preparation ["No fasting required", "No medication change required", "Mandatory pre-genetic counselling session"] Indications ["Suspected Pyruvate Dehydrogenase E2 Deficiency", "Family history of metabolic disorders", "Unexplained neurological symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 94248-9 ICD-10: E74.4 Clinical summary This genetic test identifies pathogenic variants in the DLAT gene associated with Pyruvate Dehydrogenase E2 Deficiency.
TEST-4508 DLX3 Gene Trichodentoosseous Syndrome Genetic Test This test evaluates the DLX3 gene for mutations associated with Trichodentoosseous Syndrome (TDO). It identifies pathogenic variants causing hair, dental, and bone abnormalities.	Peripheral Whole Blood or FTA Card Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DLX3 gene sequence", "Single nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation ["No fasting required", "No medication cessation required"] Indications ["Suspected Trichodentoosseous Syndrome", "Family history of TDO", "Carrier screening for at-risk relatives", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 21637-8 ICD-10: Q87.8 Clinical summary This test evaluates the DLX3 gene for mutations associated with Trichodentoosseous Syndrome (TDO). It identifies pathogenic variants causing hair, dental, and bone abnormalities.
TEST-2275 DLX5 Gene Split-Hand/Foot Malformation Type 1 with Sensorineural Hearing Loss Genetic Test This genetic test evaluates the DLX5 gene for pathogenic mutations linked to Split-Hand/Foot Malformation Type 1 and sensorineural hearing loss.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the DLX5 gene", "Coding regions and splice sites of DLX5"] Parameters [] Preparation ["Pre-test genetic counseling session is mandatory.", "Informed consent must be documented."] Indications ["Diagnosis of Split-Hand/Foot Malformation Type 1 (SHFM1)", "Diagnosis of sensorineural hearing loss associated with DLX5 mutations", "Genetic counseling for families with a history of SHFM1 or related hearing loss"] Measurement technique Confirm with laboratory Codes LOINC: 93711-0 ICD-10: Q71.6, Q72.5, Q73.8, H90.3 Clinical summary This genetic test evaluates the DLX5 gene for pathogenic mutations linked to Split-Hand/Foot Malformation Type 1 and sensorineural hearing loss.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.